FibroGen (FGEN) EV/EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| EV/EBITDA | ? | -3.45 | -4.13 | -0.07 | -9.58 | 1.17 | 1.11 | |
| Changes by years, y/y, % | -96% | +19% | -98% | +13 749% | -112% | |||
FibroGen. EV/EBITDA
FibroGen. EV/EBITDA, changes, %
FibroGen (FGEN) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -5.04 | -0.56 | 0.37 | 1.17 | 1.92 | 1.11 | |
| Changes by years, y/y, % | +401% | +1 108% | +404% | -347% | -138% | |||
| Changes by quarters, q/q, % | +968% | -89% | -167% | +214% | +64% | |||